Antonio Moreno

1.9k citations

34 papers · 427 indexed · h-index 13

Co-authors: Alejandro Rodríguez J.P. De La Cruz Felipe Sánchez de la Cuesta María Bodi Raquel Carbonell Ignacio Martín‐Loeches Josep Gómez Sandra Trefler
Topics: Sepsis Diagnosis and Treatment (8 papers)Pneumonia and Respiratory Infections (7 papers)Retinal Diseases and Treatments (5 papers)
Cited by: Critical Care and Intensive Care Medicine Infectious Diseases Epidemiology
Journals: European Journal of Pharmacology Intensive Care Medicine Journal of Antimicrobial Chemotherapy
Partner nations: Spain United States Colombia

In The Last Decade

Antonio Moreno

32 papers receiving 420 citations

Peers

Countries citing papers authored by Antonio Moreno

Since Specialization

Citations

This map shows the geographic impact of Antonio Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Moreno more than expected).

Fields of papers citing papers by Antonio Moreno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Moreno. The network helps show where Antonio Moreno may publish in the future.

Co-authorship network of co-authors of Antonio Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Moreno. A scholar is included among the top collaborators of Antonio Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Moreno. Antonio Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identificación precoz de hipofibrinogenemia en enfermedad traumática grave: la utilidad de la escala FiT-6 (Fibrinogen in Trauma-6 Score) 2025 ·Medicina Intensiva ·(unknown),Gonzalo Sirgo,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),María Bodi,Alejandro Rodríguez,Antonio Moreno	0
2	Effectiveness of prolonged versus standard‐course of oseltamivir in critically ill patients with severe influenza infection: A multicentre cohort study 2023 ·Journal of Medical Virology ·Antonio Moreno,Raquel Carbonell,Emili Dı́az,Ignacio Martín‐Loeches,Marcos I. Restrepo,Luis Felipe Reyes,Jordi Solé‐Violán,María Bodi,(unknown),Juan Guardiola,Sandra Trefler,Loreto Vidaur,Elisabeth Papiol,Lorenzo Socías,Eudald Correig,Judith Marín‐Corral,Alejandro Rodríguez,(unknown)	3
3	The Role of Biomarkers in Influenza and COVID-19 Community-Acquired Pneumonia in Adults 2023 ·Antibiotics ·Raquel Carbonell,Antonio Moreno,Ignacio Martín‐Loeches,María Bodi,Alejandro Rodríguez	14
4	Timing of intubation and ICU mortality in COVID-19 patients: a retrospective analysis of 4198 critically ill patients during the first and second waves 2023 ·BMC Anesthesiology ·(unknown),Laura Claverías,Mònica Magret,Joan Ramón Masclans,María Bodi,Sandra Trefler,(unknown),Emili Dı́az,Jordi Solé‐Violán,(unknown),(unknown),Antonio Moreno,Montserrat Vallverdú,Juan Ballesteros,Lorenzo Socías,F. Gordo Vidal,Susana Sancho,Ignacio Martín‐Loeches,Alejandro Rodríguez	10
5	Impact of macrolide treatment on long-term mortality in patients admitted to the ICU due to CAP: a targeted maximum likelihood estimation and survival analysis 2023 ·Critical Care ·Luis Felipe Reyes,(unknown),Elsa D. Ibáñez-Prada,Cristian C. Serrano-Mayorga,Yuli V. Fuentes,Alejandro Rodríguez,Antonio Moreno,Alirio Bastidas,Josep Gómez,(unknown),Christopher R. Frei,Leo Anthony Celi,Ignacio Martín‐Loeches,Grant Waterer	12
6	Prior influenza vaccine is not a risk factor for bacterial coinfection in patients admitted to the ICU due to severe influenza 2022 ·Medicina Intensiva (English Edition) ·(unknown),Luis Felipe Reyes,(unknown),Ignacio Martín‐Loeches,Emili Dı́az,Borja Suberviola,Antonio Moreno,María Bodi,Mercedes Nieto,Ángel Estella,Jordi Solé‐Violán,Daniel Curcio,Elisabeth Papiol,Juan Guardiola,Alejandro Rodríguez	2
7	Antibiotics in development for multiresistant gram-negative bacilli 2022 ·Medicina Intensiva (English Edition) ·Alejandro Rodríguez,Antonio Moreno,(unknown),Ignacio Martín‐Loeches	1
8	Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia 2021 ·Antibiotics ·Raquel Carbonell,Antonio Moreno,Ignacio Martín‐Loeches,Frederic Gómez‐Bertomeu,(unknown),Josep Gómez,María Bodi,Emili Dı́az,Elisabeth Papiol,Sandra Trefler,Mercedes Nieto,Ángel Estella,María Herrera,Pablo Vidal,Juan Guardiola,Jordi Solé‐Violán,Alejandro Rodríguez	12
9	Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia 2021 ·ERJ Open Research ·Antonio Moreno,Alejandro Rodríguez,Jordi Solé‐Violán,Ignacio Martín‐Loeches,Emili Dı́az,María Bodi,Luis Felipe Reyes,Josep Gómez,Juan Guardiola,Sandra Trefler,Loreto Vidaur,Elisabeth Papiol,Lorenzo Socías,Carolina García‐Vidal,Eudald Correig,Judith Marín‐Corral,Marcos I. Restrepo,Jonathan S. Nguyen‐Van‐Tam,Antoní Torres	17
10	Prior influenza vaccine is not a risk factor for bacterial coinfection in patients admitted to the ICU due to severe influenza 2021 ·Medicina Intensiva ·(unknown),Luis Felipe Reyes,(unknown),Ignacio Martín‐Loeches,Emili Dı́az,Borja Suberviola,Antonio Moreno,María Bodi,Mercedes Nieto,Ángel Estella,Jordi Solé‐Violán,Daniel Curcio,Elisabeth Papiol,Juan Guardiola,Alejandro Rodríguez	0
11	Revisión sistemática sobre la utilidad pronóstica del dímero-D, coagulación intravascular diseminada y tratamiento anticoagulante en pacientes graves con COVID-19 2020 ·Medicina Intensiva ·Antonio Moreno,Raquel Carbonell,María Bodi,Alejandro Rodríguez	13
12	Associated risk factors and outcomes of acute kidney injury in severe trauma: Results from the Spanish trauma ICU registry (RETRAUCI) 2020 ·Anaesthesia Critical Care & Pain Medicine ·Mario Chico‐Fernández,Jesús Abelardo Barea‐Mendoza,(unknown),Antonio Moreno,(unknown),(unknown),(unknown),M.Á. Ballesteros,Jon Pérez‐Bárcena,Juan Antonio Llompart‐Pou	7
13	Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study 2018 ·Intensive Care Medicine ·Antonio Moreno,Alejandro Rodríguez,Luis Felipe Reyes,Josep Gómez,Jordi Solé‐Violán,Emili Dı́az,María Bodi,Sandra Trefler,Juan Guardiola,Juan Carlos Yébenes,Àlex Soriano,José Garnacho‐Montero,Lorenzo Socías,María del Valle Ortiz,Eudald Correig,Judith Marín‐Corral,(unknown),Marcos I. Restrepo,Antoní Torres,Ignacio Martín‐Loeches,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	101
14	Validation of the ICU-DaMa tool for automatically extracting variables for minimum dataset and quality indicators: The importance of data quality assessment 2018 ·International Journal of Medical Informatics ·Gonzalo Sirgo,(unknown),Josep Gómez,Antonio Moreno,Alejandro Rodríguez,Lluís Blanch,Juan Guardiola,(unknown),(unknown),María Bodi	21
15	Risk Factors for Noninvasive Ventilation Failure in Critically Ill Subjects With Confirmed Influenza Infection 2017 ·Respiratory Care ·Alejandro Rodríguez,C. Ferri,Ignacio Martín‐Loeches,Emili Dı́az,Joan Ramón Masclans,Federico Gordo,Jordi Solé‐Violán,María Bodi,Francesc Xavier Avilés‐Jurado,Sandra Trefler,Mònica Magret,Antonio Moreno,Luis Felipe Reyes,Judith Marín‐Corral,Juan Carlos Yébenes,Martin Dres,Antonio Anzueto,Stefano Aliberti,Marcos I. Restrepo,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	41
16	Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C) 2013 ·Journal of Antimicrobial Chemotherapy ·Beatriz Hernández‐Novoa,Antonio Moreno,Maria Jesús Pérez‐Elías,Carmen Quereda,Fernando Dronda,José L. Casado,Nadia Madrid-Elena,(unknown),(unknown),José Moltó,Santiago Moreno	16
17	Level of Acceptance of a Clinical Solid Organ Xenotransplantation Program Among Personnel in Organ Transplant-Related Services in Spanish, Mexican, and Cuban Hospital Centers 2010 ·Transplantation Proceedings ·Antonio Ríos,L. Martínez‐Alarcón,Marco Antonio Ayala‐García,María José Quiles Sebastián,Anselmo Abdo Cuza,A. López‐Navas,P. López Cubillana,(unknown),Antonio Moreno,(unknown),(unknown),(unknown),(unknown),Miguel Ángel Martínez,Ana Nieto,G. Ramis,Pablo Ramı́rez,Pascual Parrilla	13
18	Gender differences in the effect of aspirin on retinal ischemia, prostanoid synthesis and nitric oxide production in experimental type 1-like diabetes 2007 ·Vascular Pharmacology ·José Antonio González Correa,M.M. Arrebola,Javier Muñoz-Marín,Antonio Moreno,A. Guerrero,(unknown),Felipe Sánchez de la Cuesta,J.P. De La Cruz	6
19	Nitric Oxide-cGMP and Prostacyclin-cAMP Pathways in Patients with Type II Diabetes and Different Types of Retinopathy 2002 ·Pathophysiology of Haemostasis and Thrombosis ·J.P. De La Cruz,Antonio Moreno,A. Guerrero,(unknown),José Antonio González Correa,Felipe Sánchez de la Cuesta	8
20	Effect of camonagrel, a selective thromboxane synthase inhibitor, on retinal vascularization in experimental diabetes 1998 ·European Journal of Pharmacology ·J.P. De La Cruz,Antonio Moreno,(unknown),(unknown),Felipe Sánchez de la Cuesta	16

About Antonio Moreno

Antonio Moreno is a scholar working on Critical Care and Intensive Care Medicine, Ophthalmology and Internal Medicine, having authored 34 papers that have together received 427 indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (8 papers), Pneumonia and Respiratory Infections (7 papers) and Retinal Diseases and Treatments (5 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (81 citations), Infectious Diseases (100 citations) and Epidemiology (174 citations). Antonio Moreno has collaborated with scholars based in Spain, United States and Colombia. Frequent co-authors include Alejandro Rodríguez, J.P. De La Cruz, Felipe Sánchez de la Cuesta, María Bodi, Raquel Carbonell, Ignacio Martín‐Loeches, Josep Gómez, Sandra Trefler, Juan Guardiola and Emili Dı́az. Their work appears in journals such as European Journal of Pharmacology, Intensive Care Medicine and Journal of Antimicrobial Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact